BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27752890)

  • 1. HFE genetic variability and risk of alcoholic liver disease: A meta-analysis.
    Xu YY; Tang YH; Guo XP; Wang J; Yao P
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):626-633. PubMed ID: 27752890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE gene mutations in patients with alcoholic liver disease. A prospective study from northwestern Poland.
    Raszeja-Wyszomirska J; Kurzawski G; Zawada I; Suchy J; Lubinski J; Milkiewicz P
    Pol Arch Med Wewn; 2010 Apr; 120(4):127-31. PubMed ID: 20424537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.
    Lv YF; Chang X; Hua RX; Yan GN; Meng G; Liao XY; Zhang X; Guo QN
    J Cell Mol Med; 2016 Jul; 20(7):1219-33. PubMed ID: 26893171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson's disease: A meta-analysis.
    Xia J; Xu H; Jiang H; Xie J
    Neurosci Lett; 2015 May; 595():99-103. PubMed ID: 25863172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls.
    Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A
    Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hfe mutations and iron overload in patients with alcoholic liver disease.
    Costa-Matos L; Batista P; Monteiro N; Henriques P; Girão F; Carvalho A
    Arq Gastroenterol; 2013; 50(1):35-41. PubMed ID: 23657305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HFE gene C282Y and H63D mutations with liver cirrhosis in the Lithuanian population.
    Juzėnas S; Kupčinskas J; Valantienė I; Šumskienė J; Petrenkienė V; Kondrackienė J; Kučinskas L; Kiudelis G; Skiecevičienė J; Kupčinskas L
    Medicina (Kaunas); 2016; 52(5):269-275. PubMed ID: 27816425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis of the Association between H63D and C282Y Polymorphisms in HFE and Cancer Risk.
    Zhang M; Xiong H; Fang L; Lu W; Wu X; Wang YQ; Cai ZM; Wu S
    Asian Pac J Cancer Prev; 2015; 16(11):4633-9. PubMed ID: 26107216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis.
    Zeng T; Zhang CL; Han XY; Zhao S; Xie KQ
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1183-9. PubMed ID: 23587862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.
    Ellervik C; Birgens H; Tybjaerg-Hansen A; Nordestgaard BG
    Hepatology; 2007 Oct; 46(4):1071-80. PubMed ID: 17828789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implicating the H63D polymorphism in the HFE gene in increased incidence of solid cancers: a meta-analysis.
    Shen LL; Gu DY; Zhao TT; Tang CJ; Xu Y; Chen JF
    Genet Mol Res; 2015 Oct; 14(4):13735-45. PubMed ID: 26535689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H63D mutation of the hemochromatosis gene is associated with sustained virological response in chronic hepatitis C patients treated with interferon-based therapy: a meta-analysis.
    Li SH; Zhao H; Ren YY; Liu YZ; Song G; Ding P; Ding YP; Wang GQ
    Tohoku J Exp Med; 2012 Apr; 226(4):293-9. PubMed ID: 22499121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.
    Ye Q; Qian BX; Yin WL; Wang FM; Han T
    PLoS One; 2016; 11(9):e0163423. PubMed ID: 27657935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C282Y polymorphism in the HFE gene is associated with risk of breast cancer.
    Liu X; Lv C; Luan X; Lv M
    Tumour Biol; 2013 Oct; 34(5):2759-64. PubMed ID: 23681799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C282Y and H63D Polymorphisms in Hemochromatosis Gene and Risk of Parkinson's Disease: A Meta-Analysis.
    Duan C; Wang M; Zhang Y; Wei X; Huang Y; Zhang H; Cheng L; Gai Z
    Am J Alzheimers Dis Other Demen; 2016 May; 31(3):201-7. PubMed ID: 26340960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between HFE polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis of 22 studies including 4,365 cases and 8,652 controls.
    Lin M; Zhao L; Fan J; Lian XG; Ye JX; Wu L; Lin H
    Mol Biol Rep; 2012 Mar; 39(3):3089-95. PubMed ID: 21701828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease.
    Ropero Gradilla P; Villegas Martínez A; Fernández Arquero M; García-Agúndez JA; González Fernández FA; Benítez Rodríguez J; Díaz-Rubio M; de la Concha EG; Ladero Quesada JM
    Rev Esp Enferm Dig; 2001 Mar; 93(3):156-63. PubMed ID: 11469076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis.
    Jin F; Qu LS; Shen XZ
    J Exp Clin Cancer Res; 2010 Mar; 29(1):18. PubMed ID: 20196837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
    Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ALLELES C282Y AND H63D HFE GENE, INSULIN RESISTANCE AND SUSCEPTIBILITY TO DISTURBANCE OF PORPHYRIN METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE].
    Krivosheev AB; Maximov VN; Voevoda MI; Kuimov AD; Kondratova MA; Tuguleva TA; Koval ON; Bezrukova AA; Bogorianova PA; Rybina OV
    Eksp Klin Gastroenterol; 2015; (3):39-44. PubMed ID: 26281176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.